Aero Cargo International France, the ECS Group subsidiary that has served as CORSAIR’s GSSA partner for four decades, pharma logistics specialist Healthc’Air, and CORSAIR have teamed up for 20 weeks, to establish an end-to-end pharmaceutical shipment management. The initiative kicked off with a detailed lane risk assessment covering quoting, booking, and ground handling processes, aimed at identifying and eliminating deviations that could compromise shipment integrity. Pharmaceutical cargo has become a strategic priority across the logistics industry, particularly as shipments shift rapidly from sea to air during crises, relying on partners capable of adapting capacity offers and routings, accordingly. For CORSAIR, staying flexible while meeting rigorous pharma compliance standards is critical to breaking into high-value segments such as oncology treatments and human organ transport. The rollout follows three pillars: mapping existing network, station, and fleet capabilities; building an operational database that bridges theory and practice; and implementing and fine-tuning processes as the product goes live.
Guillaume Tourneret, Managing Director France of Aero Cargo International explained: “Pharmaceutical cargo is a high-yield, strategic growth driver for CORSAIR. It already exceeds 4% of annual tonnage and more than doubles on exports to the French Overseas network, with rates 15–20% above General Cargo. Our focus is to convert that potential into revenue by maximizing load factors, tightening operational control, and securing a stronger position in pharma tenders. Through our collaboration with CORSAIR and Healthc’Air, we are delivering an audit-ready, end-to-end solution that strengthens competitiveness and positions the airline as a trusted partner for high-value pharmaceutical flows.”
Yulia Celetaria, Global Director Pharma of Healthc’Air, detailed: “We kicked-off the implementation with the pharma training of the commercial team, followed by the discussions and meetings to better understand day-to-day processes and how communication with CORSAIR is structured. […] Being pharma-audit ready at any given moment increases customers’ trust [allowing CORSAIR to] steadily increase volumes.” Jean Ceccaldi, Chief Executive Officer of ECS Group, concluded: “Collaboration creates the strongest solutions, and on behalf of ECS Group, I would like to thank the CORSAIR, Healthc’Air and Aero Cargo teams, for their key contributions to this success.”
